Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03941756 · ClinicalTrials.gov registry record · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
A NA study of Melanoma and Anatomic Stage III Breast Cancer AJCC v8, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 252
- Enrollment target
- 1
- Study location
NCT03941756: Recruiting NA study of Melanoma and Anatomic Stage III Breast Cancer AJCC v8, sponsored by M.D. Anderson Cancer Center.
NCT03941756 is a NA study of Melanoma and Anatomic Stage III Breast Cancer AJCC v8 that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 252 participants, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (64% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03941756, a NA study of Melanoma and Anatomic Stage III Breast Cancer AJCC v8, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 252 participants
- Enrollment target
- 1
- Study location
Study Summary
This pilot trial studies whether a procedure called lymphovenous bypass would prevent lymphedema (arm swelling) in patients with inflammatory breast cancer or non-inflammatory breast cancer that has spread to nearby tissues or lymph nodes or melanoma. The lymphovenous bypass procedure creates a path for lymphatic fluid to flow away from the arms. It is usually done after a diagnosis of lymphedema. In this study, giving lymphovenous bypass before underarm lymph node surgery may help prevent lymphedema from forming.
Primary Outcome
If the limb volume change, meets the criteria for a diagnosis of lymphedema at any time (5 percent, change), then the patient receives a diagnosis of lymphedema.
Conditions Studied
Interventions
- DRUG Indocyanine Green
- PROCEDURE Lymphangiography
- PROCEDURE Lymphovenous Bypass
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 252 participants |
| Start Date | 2018-08-14 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT03941756 shows while recruiting
NCT03941756 is an interventional study that assigns participants to a tested intervention. The registered 252 participants enrollment target is mid-sized for trials with a published cap, below the 706-participant average among 266 other Melanoma trials with a reported enrollment target (64% lower).
The record links to 4 conditions, with Melanoma appearing as the primary indexed condition, and to 3 interventions - of which Indocyanine Green is the first listed.
NCT03941756 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT03941756 about?
NCT03941756 is a clinical study titled "Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma". This pilot trial studies whether a procedure called lymphovenous bypass would prevent lymphedema (arm swelling) in patients with inflammatory breast cancer or non-inflammatory breast cancer that has spread to nearby tissues or lymph nodes or melanoma. The lymphovenous bypass procedure creates a path...
What is the current status of trial NCT03941756?
This trial is currently recruiting. It is a NA study. The enrollment target is 252 participants. The study started on 2018-08-14. Estimated completion is 2025-12-31.
What conditions does trial NCT03941756 study?
This clinical trial studies the following conditions: Melanoma, Anatomic Stage III Breast Cancer AJCC v8, Locally Advanced Breast Carcinoma, Breast Inflammatory Carcinoma.
What interventions are being tested in trial NCT03941756?
The interventions under investigation include: Indocyanine Green (DRUG), Lymphangiography (PROCEDURE), Lymphovenous Bypass (PROCEDURE).
Who is sponsoring clinical trial NCT03941756?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03941756 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Melanoma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03941756's enrollment target sits among peer trials
252 60th of 266 higher than 207 of 266 other Melanoma trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Melanoma trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Promoting Immunotherapy Efficacy With Low-Dose Liver RT
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
MySmartSkin Online Skin Self-exam Intervention for Melanoma Survivors
RECRUITING · NA
-
Studying Quality of Life Inclusive of Mental Health and Cognitive Behavioral Therapy for Cancer Distress for the Improvement of Quality of Life in Stage III-IV Melanoma Patients
RECRUITING · NA
-
High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies
RECRUITING · NA
-
In Vivo Liquid Biopsy of Melanoma (Cytophone)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
- NCT05384158 · 252 participants · NA
Valuation in Depressed Mood, Anhedonia, and Anxiety
- NCT05465044 · 252 participants · NA
Incremental Hemodialysis for Veterans in the First Year of Dialysis (IncHVets)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI